Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications Health Condition 2: I509- Heart failure, unspecified Health Condition 3: N189- Chronic kidney disease, unspecified
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Mohammad Mushraf
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 18 years and above. Patients prescribed with SGLT2 inhibitors attending departments of cardiology, nephrology, endocrinology and general medicine OPD.
Exclusion criteria
Exclusion criteria: Patients with incomplete or irrecoverable medical records Patients who refused to provide informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of the utilization pattern of SGLT2 inhibitors including type of drug indication dose frequency and durationTimepoint: At the time of record review | — |
Secondary
| Measure | Time frame |
|---|---|
| To characterize the clinical and comorbidities of patients prescribed with SGLT2 inhibitorsTimepoint: At the time of record review;To assess concomitant medications prescribed along with SGLT2 inhibitorsTimepoint: At the time of record review;Evaluation of potential drug-drug interactionsTimepoint: At the time of record review;Recording of Adverse Drug Reactions in the study populationTimepoint: At the time of record review | — |
Countries
India
Contacts
Public ContactCijo George
Karavali college of pharmacy
Outcome results
None listed